FDA and EMA Accept Marstacimab Regulatory Submissions for the Treatment of Hemophilia A and B
Le Lézard,
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics…
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics…
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society…
- Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics…
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics…